Tenet Healthcare Corporation (NYSE:THC – Get Free Report) Director J Robert Kerrey sold 5,638 shares of the company’s stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $174.52, for a total value of $983,943.76. Following the completion of the sale, the director owned 16,804 shares of the company’s stock, valued at approximately $2,932,634.08. The trade was a 25.12% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
Tenet Healthcare Trading Up 0.9%
NYSE:THC traded up $1.63 during trading hours on Friday, hitting $174.83. The company had a trading volume of 1,420,925 shares, compared to its average volume of 1,469,041. The company has a current ratio of 1.36, a quick ratio of 1.30 and a debt-to-equity ratio of 1.96. The company has a 50-day moving average of $189.94 and a 200 day moving average of $201.87. The company has a market cap of $15.06 billion, a P/E ratio of 9.09, a P/E/G ratio of 1.14 and a beta of 1.30. Tenet Healthcare Corporation has a 1 year low of $146.60 and a 1 year high of $247.21.
Tenet Healthcare (NYSE:THC – Get Free Report) last issued its earnings results on Thursday, April 30th. The company reported $4.82 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.21 by $0.61. Tenet Healthcare had a return on equity of 25.55% and a net margin of 7.94%.The company had revenue of $5.37 billion during the quarter, compared to analysts’ expectations of $5.39 billion. During the same period in the prior year, the business earned $4.36 EPS. The firm’s quarterly revenue was up 2.6% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. Sell-side analysts expect that Tenet Healthcare Corporation will post 17.67 earnings per share for the current year.
Analyst Upgrades and Downgrades
Check Out Our Latest Stock Analysis on Tenet Healthcare
Hedge Funds Weigh In On Tenet Healthcare
Several hedge funds have recently bought and sold shares of THC. Triumph Capital Management acquired a new position in Tenet Healthcare during the 3rd quarter worth about $25,000. Activest Wealth Management acquired a new stake in Tenet Healthcare in the 4th quarter valued at about $26,000. Elyxium Wealth LLC acquired a new stake in Tenet Healthcare in the 4th quarter valued at about $29,000. Canada Pension Plan Investment Board acquired a new stake in Tenet Healthcare in the 2nd quarter valued at about $35,000. Finally, Meeder Asset Management Inc. raised its position in Tenet Healthcare by 146.2% in the 4th quarter. Meeder Asset Management Inc. now owns 192 shares of the company’s stock valued at $38,000 after purchasing an additional 114 shares in the last quarter. Institutional investors and hedge funds own 95.44% of the company’s stock.
Tenet Healthcare Company Profile
Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.
In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.
Read More
- Five stocks we like better than Tenet Healthcare
- Shares Fall, Targets Rise—Markets and Analysts Diverge on Synopsys
- Salesforce Stock Finds Support as AI Momentum Builds
- Dollar Tree Keeps Winning After Family Dollar Divorce
- Apple’s Agentic AI Plans Could Be Its Biggest Growth Story Yet
Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
